Plunkett Research Online: Lisata Therapeutics Inc

LISATA THERAPEUTICS INC (LSTA) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the.....


LISATA THERAPEUTICS INC

Ticker: LSTA
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 212-584-4180
Fax: 646-514-7787
Address: 420 Lexington Ave., Ste. 350
New York, NY 10170 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

David Mazzo CEO/CFO/Chief Accounting Officer/Director/President
Gregory Brown Chairman of the Board/Director
See More
Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the.....See More See More

$USD, In whole numbers 2020 2019 2018 2017 2016 2015 2014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture